Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 15 (TBC1D15) is a cytosolic protein containing a conserved TBC (Tre-2/Bub2/Cdc16) domain and functions as a GTPase-activating protein (GAP) for Rab GTPases, primarily Rab7, with weaker activity on Rab11[1][3][4]. Its major role is to promote the conversion of active Rab7-GTP to inactive Rab7-GDP, thereby regulating late endosomal trafficking and vesicle transport[3][4]. TBC1D15 is ubiquitously expressed and evolutionarily conserved, with structural similarity to yeast Ypt/Rab-GAPs such as Gyp7p[1][3]. Mutations or altered expression of TBC1D15 have been associated with neurodegenerative and developmental diseases, specifically Charcot-Marie-Tooth disease type 2B and Warburg Micro syndrome 4[4]. There is also growing evidence that members of the TBC1 domain family play roles in cancer metabolism and prognosis, although direct mechanisms and therapeutic implications for TBC1D15 remain under investigation[5].
Stimulates the intrinsic GTPase activity of Rab7 (and to a lesser extent Rab11), promoting inactivation of these Rab GTPases and regulating vesicle trafficking
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 15 (TBC1D15).